Board of directors
Lars Eric Utterman, Chairman
Lars Eric Utterman is Chairman of the board of Ludesi AB and Cellectricon AB and board member of LIVC Technologies GmbH. As an executive consultant he was engaged by Gyros during 2008 and now serves as interim manager of IonGate Biosciences GmbH.
He has held a number of executive positions at international level for more than 30 years with GE Healthcare, Amersham, Pharmacia and Boehringer Mannheim (now Roche Diagnostics).
Hans Andreasson
Senior Investment Director, SLS Invest
Mr. Andreasson began his career as a researcher with EKA Nobel AB and has since then held various positions at Katalistiks BV, Arthur D. Little International Inc. Pharmacia Diagnostics AB.
In 1999, he co-founded the venture capital fund Innoventus and served as CEO from its inception. The investment focus was life science, with a particular interest in the Uppsala/Stockholm region. In October 2002, Innoventus merged operations with SLS Venture.
Mr. Andreasson is a board member of AdvanDx Inc, Aerocrine AB and Quiatech AB.
Martin Olin
Senior Investment Director, SLS Invest
Martin Olin Andersen is Senior Partner of Scandinavian Life Science Ventures (SLSV). Previous positions include Finance Director at Novo Nordisk A/S, Manager in Corporate Finance at Novo Nordisk, and Senior Accountant Management consultant at PricewaterhouseCoopers. Mr. Olin Andersen holds a Master of Science degree in Business Administration and Auditing and an Executive MBA from the Scandinavian International Management Institute.
At SLSV, Mr. Olin Andersen has lead several of its investments and he serves on the board of Light Sciences Oncology Inc., Metacure Inc., Cellectricon AB, NsGene A/S, Chempilots A/S and Precisense A/S.
Jack Johansen
Jack Johansen is an executive consultant to various life science/venture capital companies, including Novo A/S. From 1995-2001, he was a founding CEO of two life science diagnostic companies, Boston Biosystems, Inc. and Boston Probes, Inc., both of which were sold. Prior to this, he was Executive Vice President of science and technology at Millipore Corporation and President of Millicorp, which is Millipore's venture fund.
Dr. Johansen is Chairman of the Board of Directors of AdvanDx Inc. and serves on the Board of Directors of Symphogen A/S and 7TM A/S.
Jörgen Lönngren
Stiftelsen Industrifonden
Industrifonden is a major Swedish investor in life science companies.
Before joining Industrifonden in 2000 Dr. Lönngren was the President of Professional Genetics Laboratory AB – a service laboratory for the global pharma industry.
During 1982 to 1993 he served in various senior management positions including Head of R&D at Pharmacia Biotech AB (now GE Healthcare Life Sciences) – a leading supplier of biotechnology tools.
Dr. Lönngren also serves on the Boards of several young biotechnology companies. He holds a PhD in chemistry from Stockholm University.
